Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

motion sickness - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

motion sickness

MONDO:0008015

Also known as:travel sickness

Find Clinical TrialsTrials

Overview

A sensation of discomfort that results from a discordant relationship between visualized movement and any movement sensed by the vestibular system, which is characterized by dizziness, nausea, and vomiting.

Treatments1 FDA approved

Clinical Trials9 registered · 3 recruiting

Clinical Presentation

Features include: Nervous system problems (abnormality of the nervous system).

Organ System	Phenotype Count	Example Features
Brain and nerves	1	Nervous system problems (abnormality of the nervous system)

Explore clinical features

Diagnosis

Biomarker and diagnostic research for motion sickness has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for motion sickness, including SCOPOLAMINE (TRANSDERM SCOP, approved 1979).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

9 clinical trials registered, 3 recruiting. Interventions under study include other interventions, medical devices, and drug therapy. Pipeline includes 1 PHASE3, 2 PHASE2, 4 NA. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT06892340](https://clinicaltrials.gov/study/NCT06892340)

Data assembled from 6 of 12 sources · Last updated Sep 17, 2026, 9:37 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:158280

Questions for Your Care Team

→What are the benefits and potential side effects of TRANSDERM SCOP for managing motion sickness?
→Are any of the 9 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	63	44%
Research summaries	27	19%
Clinical study results	22	15%
Disease patterns and progression	17	12%
Testing and diagnosis research	8	6%
New treatment approaches	3	2%
Other research	1	1%
Patient case studies	1	1%

motion sickness

Overview

Clinical Presentation

Explore clinical features

Diagnosis

Treatment

Approved Therapies

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications